Goldman Sachs
SKIN icon

Goldman Sachs’s SkinHealth Systems SKIN Stock Holding History

Goldman Sachs’s Portfolio SKIN Stock Details SKIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$83.8K Sell
121,025
-505,854
-81% -$387K ﹤0.01% 6354
2026
Q1 		$558K Buy
626,879
+159,971
+34% +$196K ﹤0.01% 5534
2025
Q4 		$649K Sell
466,908
-9,108
-2% -$13.2K ﹤0.01% 5437
2025
Q3 		$947K Buy
476,016
+144,393
+44% +$293K ﹤0.01% 5063
2025
Q2 		$633K Sell
331,623
-334,083
-50% -$470K ﹤0.01% 5017
2025
Q1 		$892K Buy
665,706
+31,880
+5% +$48.6K ﹤0.01% 4771
2024
Q4 		$1.01M Buy
633,826
+215,044
+51% +$338K ﹤0.01% 4814
2024
Q3 		$603K Buy
418,782
+32,489
+8% +$53.2K ﹤0.01% 4946
2024
Q2 		$742K Sell
386,293
-97,965
-20% -$276K ﹤0.01% 4600
2024
Q1 		$2.15M Buy
484,258
+10,823
+2% +$35.2K ﹤0.01% 3814
2023
Q4 		$1.47M Sell
473,435
-366,502
-44% -$1.38M ﹤0.01% 4157
2023
Q3 		$5.06M Buy
839,937
+196,096
+30% +$1.38M ﹤0.01% 2962
2023
Q2 		$5.39M Sell
643,841
-497,599
-44% -$5.17M ﹤0.01% 3038
2023
Q1 		$14.4M Sell
1,141,440
-1,902,406
-63% -$22M ﹤0.01% 2092
2022
Q4 		$27.7M Buy
3,043,846
+2,101,698
+223% +$22.7M 0.01% 1665
2022
Q3 		$11.1M Buy
942,148
+261,106
+38% +$3.3M ﹤0.01% 2411
2022
Q2 		$8.76M Sell
681,042
-191,405
-22% -$2.56M ﹤0.01% 2641
2022
Q1 		$14.7M Sell
872,447
-716,747
-45% -$11.8M ﹤0.01% 2310
2021
Q4 		$38.4M Buy
1,589,194
+1,167,449
+277% +$30.1M 0.01% 1558
2021
Q3 		$11M Buy
421,745
+364,248
+634% +$8.01M ﹤0.01% 2633
2021
Q2 		$966K Buy
+57,497
New +$786K ﹤0.01% 4788

Other funds holding SKIN

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.1B AUM 20.71% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Goldman Sachs's SKIN Position: Q2 2026 in Review

Goldman Sachs reduced its SkinHealth Systems (SKIN) stake by 81% in Q2 2026, selling an estimated $387K and leaving 121,025 shares worth $83.8K. The position accounts for ﹤0.01% of the portfolio, ranked #6354.

Goldman Sachs first reported a position in SKIN in Q2 2021 and has held it in 21 quarters since. The position peaked at $38.4M in Q4 2021. 96 funds tracked by Wall St. Rank hold SKIN as of Q2 2026.

  • Goldman Sachs held 121,025 shares of SkinHealth Systems worth $83.8K as of Q2 2026.
  • Goldman Sachs sold 505,854 SkinHealth Systems shares in Q2 2026, an estimated $387K.
  • SkinHealth Systems made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #6354 holding.
  • Goldman Sachs first reported a position in SkinHealth Systems in Q2 2021 and has held it in 21 quarters since.
  • Goldman Sachs's SkinHealth Systems position peaked at $38.4M in Q4 2021.
  • 96 funds tracked by Wall St. Rank held SkinHealth Systems as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.